HIV-1
"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
| Descriptor ID |
D015497
|
| MeSH Number(s) |
B04.820.650.589.650.350.400
|
| Concept/Terms |
HIV-1- HIV-1
- Human immunodeficiency virus 1
- HIV-I
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
|
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 9 | 4 | 13 | | 1997 | 4 | 1 | 5 | | 1998 | 13 | 2 | 15 | | 1999 | 10 | 0 | 10 | | 2000 | 13 | 4 | 17 | | 2001 | 6 | 3 | 9 | | 2002 | 11 | 5 | 16 | | 2003 | 8 | 4 | 12 | | 2004 | 12 | 8 | 20 | | 2005 | 12 | 7 | 19 | | 2006 | 18 | 1 | 19 | | 2007 | 13 | 3 | 16 | | 2008 | 14 | 8 | 22 | | 2009 | 10 | 3 | 13 | | 2010 | 18 | 4 | 22 | | 2011 | 22 | 5 | 27 | | 2012 | 18 | 8 | 26 | | 2013 | 17 | 5 | 22 | | 2014 | 26 | 11 | 37 | | 2015 | 17 | 7 | 24 | | 2016 | 21 | 9 | 30 | | 2017 | 15 | 13 | 28 | | 2018 | 17 | 9 | 26 | | 2019 | 16 | 6 | 22 | | 2020 | 12 | 10 | 22 | | 2021 | 11 | 6 | 17 | | 2022 | 19 | 1 | 20 | | 2023 | 13 | 0 | 13 | | 2024 | 11 | 4 | 15 | | 2025 | 16 | 4 | 20 | | 2026 | 13 | 3 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Rogg L, Nuñez SA, Mingrone MV, Domingo P, Rolle CP, Güerri-Fernandez R, Estrada V, Lopez M, Hanan N, Ghita GL, Jeffrey JL, Underwood M, Castillo-Mancilla JR, Halliday F, Ezeadi E, Gartland M. Proof-of-Concept Phase 2a Trial of VH4524184: An Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clin Infect Dis. 2026 Oct 28; 83(4):e819-e825.
-
Guo K, Dillon SM, Meneses EC, Barrett BS, Norman A, Mickens KL, Morrison JH, Dittmer U, Sutter K, Poeschla EM, Kechris K, Wilson CC, Santiago ML. Interferome profiling in the blood links IFNa5-Mucin-1 axis to HIV-1 pathogenesis. J Virol. 2026 Oct 20; 100(10):e0108926.
-
Olenginski LT, Batey RT. Cryptic RNA Binding Sites Are Energetically Accessible and Chemically Addressable. Biochemistry. 2026 Sep 15; 65(18):2829-2834.
-
Rallón N, Restrepo C, Manquillo A, Pérez-Sánchez C, Mahillo I, Nistal S, Al-Hayani A, Cabello A, Carrillo I, Prieto L, Górgolas M, López JC, Muñoz A, Estrada V, Benito JM. Unsupervised proteomic stratification of people living with HIV reveals inflammatory biotypes beyond conventional clinical classifications. Front Immunol. 2026; 17:1947773.
-
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL. Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. J Virol. 2026 Aug 18; 100(8):e0038926.
-
Ridolfi F, Amorim G, Haas DW, Arriaga M, Staats C, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Sterling TR, Rolla VC, Benjamin A, Sant'Anna FM, Oliveira JG, Marin J, Rezende A, Carvalho AC, Rocha M, Nogueira B, Brito A, Spener R, Turner M. Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil. Mem Inst Oswaldo Cruz. 2026; 121:e250090.
-
Lee JS, Humes E, Haw NJL, Hogan B, Zheng C, Coburn S, Lesko CR, Lang R, Gill MJ, Horberg M, Silverberg MJ, Palella FJ, Delaney JA, Rebeiro PF, Sterling T, Rodriguez-Barradas M, Marconi VC, Yendewa GA, Klein MB, Moore R, Althoff KN. Harmonizing HIV-1 RNA laboratory measurements in a longitudinal cohort collaboration. Am J Epidemiol. 2026 07 08; 195(7):2055-2063.
-
Moeser MJ, Council OD, Long N, Kincer L, Dennis AM, Eron J, Wohl D, Farel CE, Dittmer DP, Pluta L, Nelson J, Mohammadi A, Etemad B, Li JZ, McGann H, Smit E, Clement M, Yau T, Menezes P, Bowman NM, Zhou S, Joseph SB. A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage. J Infect Dis. 2026 Jun 16; 233(6):1005-1014.
-
Stabell AC, Lee S, Park DJ, Lavine CL, Espinosa SM, Baharani VA, Patejak R, Nussenzweig MC, Caskey M, Seaman MS, Bieniasz PD, Hatziioannou T. Diverse paths to broadly neutralizing antibody escape among HIV-1 strains. Nat Microbiol. 2026 Jun; 11(6):1573-1584.
-
Khaitan A, Lindsey JC, Capparelli EV, Tierney C, Coletti A, Perlowski C, Yin DE, Smith MEB, Spiegel HML, Majji S, Moye J, Gama L, Koup RA, Lin BC, McDermott AB, Purdue L, Krotje C, Harding PA, Cotton MF, Costello D, Petropoulos CJ, Reeves JD, Mallewa M, Chihana R, Kamthunzi P, Mbengeranwa TG, Masheto G, Santos Cruz ML, Pilotto JH, Ponatshego PL, Persaud D, McFarland EJ. VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines. Sci Transl Med. 2026 May 06; 18(848):eadr4509.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|